Brain Tumor Treatments: Radiation
Sponsored By
Stand Up to Cancer
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Radiation
Please scroll down past the trials to see pages on this site about this topic!

  Showing Treatment 1 to 25 of 679 Next 25 Location Last Updated
Details Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma (HBO) Great Neck & Commack, NY USA 06/02/2010
Details Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Great Neck & Commack, NY USA 06/02/2010
Details Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial. Rochester, NY USA 04/13/2010
Details RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent Houston, TX USA 03/30/2010
Details 2009-0476: A Phase I dose-finding study of XL184 administered orally in combination with Temozolomide and Radiation Therapy in first line treatment of glioblastoma Houston, TX USA 03/30/2010
Details 2008-0318: Phase I/II trial of Dasatinib (Sprycel) with Radiation Therapy and concomitant and Adjuvant Temozolomide in Patients with newly diagnosed Glioblastoma Houston, TX USA 03/29/2010
Details 2008-0059: Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma Houston, TX USA 03/29/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Chicago, IL USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Detroit, MI USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Los Angeles, CA USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Durham, NC USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Charlottesville, VA USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Cleveland, OH USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Cleveland, OH USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Hackensack, NJ USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Syracuse, NY USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Chicago, IL USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Los Angeles, CA USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Boston, MA USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Jacksonville, FL USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) New Haven, CT USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Buffalo, NY USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Salt Lake City, UT USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Columbus, OH USA 03/09/2010
Details Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) Evanston, IL USA 03/09/2010

(Relevance) Page Title - click title to go to the page!

  (0.9935)   Trials by NCT number
  (0.9574)   Trials without an NCT number
  (0.8351)   Brain Tumor Treatments: Nebraska
  (0.8351)   Brain Tumor Treatments: North Dakota
  (0.8351)   Brain Tumor Treatments: Montana
  (0.8351)   Brain Tumor Treatments: Mississippi
  (0.8351)   Brain Tumor Treatments: Maine
  (0.8351)   Links (webTV version)
  (0.8351)   Brain Tumor Treatments: Kentucky
  (0.8351)   Brain Tumor Treatments: Kansas
  (0.8351)   Brain Tumor Treatments: Indiana
  (0.8351)   Brain Tumor Treatments: Idaho
  (0.8351)   Brain Tumor Treatments: Iowa
  (0.8351)   Brain Tumor Treatments: Hawaii
  (0.8169)   Brain Tumor Treatments: Chemotherapy
  (0.8169)   Brain Tumor Treatments: Missouri
  (0.8169)   Medulloblastoma
  (0.8169)   Brain Tumor Treatments: Louisiana
  (0.7967)   Brain Tumor Treatments: Netherlands
  (0.7967)   Brain Tumor Treatments: North Carolina
  (0.7967)   Brain Tumor Treatments: Minnesota
  (0.7967)   Search for a Specific Trial or Treatment
  (0.7967)   Brain Tumor Treatments: Michigan
  (0.7967)   Brain Tumor Treatments: Maryland
  (0.7967)   Emerging Med Trials Matcher
  (0.7967)   Brain Tumor Treatments: Massachusetts
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Stereotactic Radiosurgery
  (0.7967)   Brain Tumor Treatments: Japan
  (0.7967)   Brain Tumor Trials And Treatments
  (0.7967)   Brain Tumor Trials And Treatments
  (0.7967)   Brain Tumor Trials And Treatments
  (0.7967)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Guide
  (0.7742)   Brain Tumor Treatments: China PR
  (0.7742)   Brain Tumor Chat Room
  (0.7742)   Brain tumor Chat room registration
  (0.7742)   Problem Report Received
  (0.7742)   Brain Tumor Chat Room Problem
  (0.7742)   Musella Foundation
  (0.7742)   Mohammad Abdollahian
  (0.7742)   TEST
  (0.7742)   virtualtrials.com/menu2006b.cfm
  (0.7742)   virtualtrials.com/menu2006.cfm
  (0.7742)   Meningioma List
  (0.7742)   Meningioma List
  (0.7742)   Memorials
  (0.7742)   Memorials
  (0.7742)   Memorial
  (0.7742)   Map
  (0.7742)   Map
  (0.7742)   Map
  (0.7742)   Map
  (0.7742)   Brain Tumor Treatments: Malaysia
  (0.7742)   Newsletter And Daily News Update!
  (0.7742)   Mailbox
  (0.7742)   Brain Tumor Treatments: Less Toxics
  (0.7742)   Online Support Groups
  (0.7742)   Add a Links to Brain Tumor Information
  (0.7742)   Add a Links to Brain Tumor Information
  (0.7742)   Chemotherapy For Brain Tumors
  (0.7742)   Letter Writing Campaign
  (0.7742)   Brain Tumor Treatments: Less Toxics
  (0.7742)   Brain Tumor Treatments: Less-Toxic
  (0.7742)   Karnofsky Score
  (0.7742)   Jim Racich Memorial
  (0.7742)   Mailing Lists
  (0.7742)   Mailing Lists
  (0.7742)   Brain Tumor Treatments: Italy
  (0.7742)   Brain Tumor Treatments: Israel
  (0.7742)   Brain Tumor Chat Room Question
  (0.7742)   Brain Tumor Chat room
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Immunotherapies, biological and targeted therapies
  (0.7742)   Immunotherapies, biological and targeted therapies
  (0.7742)   Image Guided Surgery
  (0.7742)   Brain Tumor Treatments: Illinois
  (0.7742)   IFN-Beta Gene Transfer
  (0.7742)   2003 Pediatric Brain Tumor Confernce
  (0.7742)   Video Library: Brainstorming Long Island 2004
  (0.7742)   Hockey fundraiser
  (0.7742)   Hockey fundraiser
  (0.7742)   Human Corticotropin-Releasing Factor (hCRF)
  (0.7742)   Brain Tumor Chat Room
  (0.7742)   Brain Tumor Chat room





Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites